Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Dendreon Corporation    

DENDREON CORPORATION

Mes dernières consult.
Top consultations
20
SynthèseGraphiquesActualitésAgendaSociétéFinancesFondsCommunauté 
OFFRE DE NOEL Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Métier
Discovers, develops and commercializes novel products for the treatment of cancer

Dendreon Corp. is a biotechnology company, which focuses on discovery, development and commercialization of novel therapeutics that improves cancer treatment options for patients.

The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types.

It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers.

Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.
Dirigeants
Nom AgeDepuisTitre
Craig R. Jalbert542015President, Secretary, Treasurer & Director
William Monteith572009Executive Vice President-Technical Operations
Andrew S. Sandler, MD502014Chief Medical Officer & Executive Vice President
April Falcone--Head-Corporate Communications
Silvio Pacheco, MBA--Chief Customer Officer
Karen Brophy522012Vice President & Head-Human Resources
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 158 716 893 153 327 147 96.6% 0 0.0% 96.6%
Secteur
Santé
Recherche pharmaceutique et médicale
 Recherche biotechnologique et médicale
  Recherche biotechnologique et médicale
   Recherche biotechnologique et médicale - NCA
Publicité
Secteur Recherche biotechnologique et médicale - NCA
Var. 1janvCapitalisation (M$)
DENDREON CORPORATION-55.48%0
QUINTILES IMS HOLDINGS..14.10%19 286
INCYTE CORPORATION-7.21%18 957
CELLTRION, INC.--.--%9 997
LONZA GROUP AG9.20%9 261
SEATTLE GENETICS, INC.44.54%9 183
ALKERMES PLC-30.12%8 430
QIAGEN NV1.77%6 810
UNITED THERAPEUTICS CO..-15.91%5 586
IONIS PHARMACEUTICALS ..-26.42%5 523
ICON PLC-1.63%4 239
BIO-TECHNE CORP19.44%4 011
ALNYLAM PHARMACEUTICAL..-55.12%3 626
INTREXON CORP0.66%3 537
CHARLES RIVER LABORATO..-7.76%3 509
PAREXEL INTERNATIONAL ..-3.98%3 484
PRA HEALTH SCIENCES IN..21.49%3 377
ACADIA PHARMACEUTICALS..-23.59%3 241
BB BIOTECH AG-5.90%2 994
GALAPAGOS-1.46%2 731
INC RESEARCH HOLDINGS ..2.76%2 689
Secteur Recherche biotechnologique et médicale - NCA
Dendreon Corporation : Connexions
Dendreon Corp.
1301 2nd Avenue
Suite 3200
Seattle, WA 98101

Phone : +1.206.256.4545
Fax : +1.206.256.0571
Web : www.dendreon.com
© 2016 People , Fundamentals and Ownership